C3 AI shares fell 14% in after-hours trading on September 3, 2025 following its Q1 earnings report and a CEO change.

The company, which develops enterprise AI software and is based in the US, reported Q1 revenue of US$70.3 million, down from US$87.2 million year-on-year.

Its GAAP net loss widened to 86 cents from a 50-cent loss a year earlier.

Stephen Ehikian, a tech executive whose previous startups were acquired by Salesforce, was appointed CEO effective September 1, 2025.

C3 AI began looking for a new CEO in July after former chief Thomas Siebel disclosed an autoimmune disease diagnosis that led to significant visual impairment.

🔗 Source: CNBC

🧠 Food for thought

1️⃣ Health-related CEO departures highlight succession planning gaps in tech

C3.AI’s leadership transition highlights challenges in corporate succession planning, particularly when health issues force sudden CEO changes.

Thomas Siebel’s departure due to an autoimmune disease causing “significant visual impairment” represents an unexpected leadership crisis that tech companies often struggle to handle smoothly1.

Research shows that 75% of tech executives express dissatisfaction with current succession processes, with many companies lacking formal plans for such circumstances2.

The immediate 14% stock drop following the CEO change announcement suggests investors had little confidence in the transition plan, despite Ehikian’s experience building two companies acquired by Salesforce1.

This reflects broader challenges in the tech sector, where CEO turnover among large-cap companies is increasing as firms transition from aggressive growth strategies to more sustainable approaches2.

2️⃣ Enterprise AI companies face monetization reality despite market enthusiasm

C3.AI’s declining revenues reveal the gap between AI market hype and actual enterprise software monetization, even for established players.

Despite operating in the hottest technology sector, C3.AI reported a 19% revenue decline to $70.3 million in Q1, down from $87.2 million the previous year1.